• Small Molecules
      • Discovery
        Development
        Manufacturing
    • Large Molecules
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers

Life at Syngene

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

Life at Syngene: In conversation with Sarah Chatterjee

Watch this video on Sarah Chatterjee, who recently completed 20 years in Syngene. She talks about her journey from trainee scientist to sales manager, Syngene’s growth from a single lab to three campuses spread across different locations, and more.

Life At Syngene – Spotlight On Chemistry Services for Drug Discovery With Dr Santosh Kulkarni

Watch this video where our Research Director, Dr. Santosh Kulkarni explains how Syngene delivers Chemistry services for drug discovery programs using cutting-edge science.

Life at Syngene: Spotlight on Clinical Development with Chetan Tamhankar

Watch this video on ‘Life at Syngene’ where we speak to Chetan Tamhankar, Head, Clinical Development services on Syngene capabilities in this space, the value we bring to our clients, future plans, and more.

Life at Syngene- Spotlight on Regulated Large Molecule Bioanalytical Lab with Dr Aparna Kasinath

Learn from our Head of bioanalytical Lab, Aparna Kasinath, how the field of biotherapeutics has evolved over the past decade,  interesting projects at Syngene, and what makes Syngene so unique as a CRO/CDMO

Life at Syngene: Spotlight on Chemical Development–Part I with Jayadeva Sajankila

Watch this video on what our Research Director, Jayadeva Sajankila, has to say on what makes Syngene unique, new expectations driving drug development today, and more. 

Life At Syngene: Spotlight On DMPK Services With Dr Vishwottam Kandikere

Watch this video on what our Head of DMPK services Dr. Vishwottam Kandikere, has to say on what sets Syngene apart, emerging trends in DMPK,  our current projects related to new modalities, and more.

Life At Syngene: Spotlight On Chemical Development–Part II With Jayadeva Sajankila

In continuation of our earlier video on ‘Life at Syngene,’ learn from our Research Director, Jayadeva Sajankila, Syngene’s unique capabilities in Solid-state chemistry and how Safety is at the heart of everything we do – personally and professionally.

Life At Syngene: Spotlight On Stability Studies- Part I with Sameer Bhide

Watch this video to get insights on how Syngene’s Stability Center, one of the largest ICH Stability Centers in Asia, is delivering successfully even in the midst of a pandemic.
 

Life At Syngene: Spotlight On Stability Studies- Part II with Sameer Bhide

In continuation with our earlier video on Stability Studies, listen to our colleague and senior scientist, Sameer Bhide speak about why Syngene is the preferred partner for ICH Stability Studies for global biopharma companies

Sign-up for our newsletter

© 2022. Syngene International Limited

Twitter Linkedin-in Youtube Facebook-f

Quick Links

Business

Get In Touch

Other Links

Twitter Linkedin-in Youtube Facebook-f

© 2022. Syngene International Limited

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close
Close

To download, Please share your details

To download, Please share your details